Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Brain tumor, adult: Meningioma/Meningeal tumors
Country:  U.S.A.
Trial Type:  Treatment
Results 1-9 of 9 for your search:
Start Over
Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BMX-HGG-001, NCI-2016-00288, NCT02655601
Increased Dose IMPT in Treating Patients with High-Grade Meningiomas
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 15-542, NCI-2016-00702, NCT02693990
Proton Beam Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma or Hemangiopericytoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 24309, NCI-2010-01084, NCT01117844
Laboratory Treated T-Cells in Treating Patients with NY-ESO-1 Expressing Metastatic or Locally Advanced Recurrent Solid Tumors or Malignant Meningioma
Status: Temporarily closed
Phase: Phase II
Type: Treatment
Age: 18 to 66
Trial IDs: 13-C-0214, NCI-2015-00137, 130214, 1308-1249, P131300, RD-13-VII-07, NCT01967823
Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: LOXO-TRK-15002, NCI-2015-01947, NCT02576431
Nivolumab in Treating Adult Patients with Recurrent High-Grade Meningioma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15-490, NCI-2016-00504, NCT02648997
Conditioning Therapy Followed by Stem Cell Transplant in Treating Patients with High Risk or Relapsed Solid, Central Nervous System, or Germ Cell Tumors
Status: Active
Phase: No phase specified
Type: Treatment
Age: 70 and under
Trial IDs: 2011OC057, NCI-2013-02265, 1107M02641, MT2011-09C, NCT01505569
Everolimus in Patients with Vestibular Schwannomas or Meningiomas Undergoing Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NYU S12-02808, NCI-2013-01174, 13211666, i12-02808, S12-02808, NCT01880749
Electric Field Therapy in Treating Patients with Recurrent Meningioma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 13-067, NCI-2013-01316, NCT01892397
Start Over